Ivor MacLeod
Director of Finance/CFO bij SCYNEXIS, INC.
Vermogen: 235 506 $ op 31-03-2024
Profiel
Ivor MacLeod is currently the Chief Financial & Accounting Officer at SCYNEXIS, Inc. Prior to this, he held positions as Vice President-Finance at Merck & Co., Inc., Vice President-Finance & Information Technology at Hoffmann-La Roche, Inc., and Chief Financial & Compliance Officer, SVP at Eisai, Inc. From 2021 to 2022, he served as the Chief Financial & Accounting Officer at Athersys, Inc. Mr. MacLeod completed his undergraduate degree at the University of St. Andrews and holds an MBA from Eller College of Management.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
SCYNEXIS, INC.
0.43% | 26-01-2024 | 160 185 ( 0.43% ) | 235 472 $ | 31-03-2024 |
ATHERSYS, INC.
0.01% | 14-08-2023 | 5 732 ( 0.01% ) | 34 $ | 31-03-2024 |
Actieve functies van Ivor MacLeod
Bedrijven | Functie | Begin |
---|---|---|
SCYNEXIS, INC. | Director of Finance/CFO | 24-10-2022 |
Eerdere bekende functies van Ivor MacLeod
Bedrijven | Functie | Einde |
---|---|---|
ATHERSYS, INC. | Director of Finance/CFO | 30-06-2022 |
MERCK & CO., INC. | Director of Finance/CFO | - |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Director of Finance/CFO | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Director of Finance/CFO | - |
Opleiding van Ivor MacLeod
University of St. Andrews | Undergraduate Degree |
Eller College of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
SCYNEXIS, INC. | Health Technology |
ATHERSYS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |